Evaluation of the effect of silymarin on cholesterol triglyceride and BMI in patients with type 2 diabetes mellitus referring to endocrine clinic of Imam khomeini hospital Urmia
Phase 1
- Conditions
- BMI and Lipid profile in type 2 DM.R4
- Registration Number
- IRCT20170814035697N4
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age between 30_65
Diagnose of diabetics according of WHO criteria FBS >126 mg/dl or 2hpp>200 mg/dl or HbA1c>9%
A history of DM is more than 1 year old
FBS<250
Conscious informed consent to participate in the study
Exclusion Criteria
Insulin therapy
for autoimmune diseases and cancer
Taking drugs that interfere with the level of plasma glucosesmoking
Smoking
Pregnancy and lactationcatching
Hospitalized or undergoing surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid profile. Timepoint: Before and after of treatment. Method of measurement: Lab data.
- Secondary Outcome Measures
Name Time Method